C

CanSense

8 employees

CanSense is an accurate, rapid, non-invasive, blood diagnostic for the early detection of cancer.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Diagnostics
Health Care
Cancer Diagnostics and AI analytics

Date founded

2018

Funding rounds raised

Total raised

$1.8M

from 3 investors over 3 rounds

C

CanSense raised $1.8M on March 8, 2023

Investors: - and Development Bank of Wales

C

CanSense raised $1.4M on January 1, 2022

Investors: National Institute for Health Research (NIHR)

FAQ